Income Statement CASI Pharmaceuticals, Inc. Nasdaq

Stocks

CASI

KYG1933S1012

Pharmaceuticals

Market Closed - Nasdaq 14:38:46 2026-10-07 EDT			5-day change	1st Jan Change
0.1100 ^USD	0.00%		-31.25%	-87.06%

08-14	CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-13	Casi Pharmaceuticals, Inc. Announces Management Changes	CI

0ac477fde00c33408e9.Un6a8T5qExSo0wTibn6cqSPRSBvQbJmrf-P1AyfNFzU.ETn4wHo4UmbS4lWRXj-qykqbe0KZXO_xJYaSR168VHscO8OmcllCYcOidw

Published financial data: CASI PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	30.17M	43.11M	33.88M	28.54M	20.71M
Total Revenues	30.17M	43.11M	33.88M	28.54M	20.71M
Cost of Goods Sold, Total	12.56M	15.83M	13.83M	17.39M	10.64M
Gross Profit	17.61M	27.28M	20.05M	11.15M	10.08M
Selling General & Admin Expenses, Total	38.47M	37.78M	41.84M	41.44M	46.61M
R&D Expenses	14.42M	16M	9.86M	8.92M	6.31M
Other Operating Expenses	-	-	-6.37M	-2K	-
Other Operating Expenses, Total	52.89M	53.77M	45.33M	50.36M	52.92M
Operating Income	-35.28M	-26.49M	-25.28M	-39.21M	-42.85M
Interest Expense, Total	-43.9K	-	-	-871K	-840K
Interest And Investment Income	365K	127K	614K	539K	135K
Net Interest Expenses	321K	127K	614K	-332K	-705K
Income (Loss) On Equity Invest.	-	-846K	-48K	-1.19M	-2.19M
Currency Exchange Gains (Loss)	321K	3.24M	200K	-192K	-2.16M
Other Non Operating Income (Expenses)	86.19K	44K	764K	188K	20K
EBT, Excl. Unusual Items	-34.55M	-23.92M	-23.75M	-40.74M	-47.88M
Gain (Loss) On Sale Of Investments	4.8M	-3.57M	-2.59M	1.7M	-179K
Gain (Loss) On Sale Of Assets	-	-2.06M	-	479K	-
Asset Writedown	-	-8.72M	-	-696K	-
In Process R&D Expenses	-6.56M	-	-	-	-
Other Unusual Items	472K	-	-	-	-
EBT, Incl. Unusual Items	-35.84M	-38.28M	-26.34M	-39.26M	-48.06M
Income Tax Expense	-	1.98M	-81K	-	-
Earnings From Continuing Operations	-35.84M	-40.26M	-26.26M	-39.26M	-48.06M
Net Income to Company	-35.84M	-40.26M	-26.26M	-39.26M	-48.06M
Minority Interest	-812K	-757K	-679K	-	-
Net Income - (IS)	-36.65M	-41.01M	-26.94M	-39.26M	-48.06M
Preferred Dividend and Other Adjustments	-	-	22K	-	-
Net Income to Common Incl Extra Items	-36.65M	-41.01M	-26.96M	-39.26M	-48.06M
Net Income to Common Excl. Extra Items	-36.65M	-41.01M	-26.96M	-39.26M	-48.06M
Per Share Items
Net EPS - Basic	-2.69	-3.01	-2.02	-2.56	-2.59
Basic EPS - Continuing Operations	-2.69	-3.01	-2.02	-2.56	-2.59
Basic Weighted Average Shares Outstanding	13.61M	13.65M	13.36M	15.34M	18.54M
Net EPS - Diluted	-2.7	-3.01	-2.02	-2.56	-2.59
Diluted EPS - Continuing Operations	-2.7	-3.01	-2.02	-2.56	-2.59
Diluted Weighted Average Shares Outstanding	13.61M	13.65M	13.36M	15.34M	18.54M
Normalized Basic EPS	-1.65	-1.15	-1.16	-1.66	-1.61
Normalized Diluted EPS	-1.65	-1.15	-1.16	-1.66	-1.61
Payout Ratio	-	-	-2.74	-1.83	-
Supplemental Items
EBITDA	-33.47M	-24.07M	-21.54M	-36.88M	-41.59M
EBITA	-33.94M	-25.28M	-23.99M	-38.15M	-42.82M
EBIT	-35.28M	-26.49M	-25.28M	-39.21M	-42.85M
EBITDAR	-32.02M	-22.77M	-20.44M	-35.68M	-40.39M
Total Revenues (As Reported)	30.17M	43.11M	33.88M	28.54M	-
Effective Tax Rate - (Ratio)	-	-5.17	0.31	-	-
Normalized Net Income	-22.41M	-15.71M	-15.52M	-25.46M	-29.92M
Interest on Long-Term Debt	2.9K	-	-	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	14.7M	14.33M	16.45M	17.87M	18.34M
General and Administrative Expenses	23.77M	23.45M	25.39M	23.58M	28.27M
Research And Development Expense From Footnotes	20.98M	16M	9.86M	8.92M	6.31M
Net Rental Expense, Total	1.45M	1.3M	1.1M	1.2M	1.2M
Imputed Operating Lease Interest Expense	190K	-	-	385K	325K
Imputed Operating Lease Depreciation	1.26M	-	-	815K	875K
Stock-Based Comp., R&D Exp. (Total)	361K	624K	236K	217K	206K
Stock-Based Comp., S&M Exp. (Total)	449K	174K	245K	329K	397K
Stock-Based Comp., G&A Exp. (Total)	6.96M	6.21M	6.74M	760K	2.38M
Total Stock-Based Compensation	7.77M	7.01M	7.22M	1.31M	2.99M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	38.7M	47.11M	17.08M	13.47M	5.63M
Short Term Investments	9.87M	4.22M	13.69M	2.62M	-
Total Cash And Short Term Investments	48.57M	51.34M	30.77M	16.09M	5.63M
Accounts Receivable, Total	9.8M	12.97M	9.55M	15.34M	4.09M
Other Receivables	-	-	587K	-	-
Total Receivables	9.8M	12.97M	10.14M	15.34M	4.09M
Inventory	1.91M	6.14M	15.88M	5.25M	1.6M
Prepaid Expenses	1.69M	2.98M	2.56M	2.89M	2.14M
Total Current Assets	61.97M	73.42M	59.34M	39.58M	13.46M
Gross Property Plant And Equipment	23.64M	15.53M	16.28M	17.07M	16.6M
Accumulated Depreciation	-1.82M	-2.3M	-4.65M	-5.71M	-7.08M
Net Property Plant And Equipment	21.82M	13.23M	11.63M	11.36M	9.52M
Long-term Investments	40.13M	7.46M	1.69M	1.91M	1.72M
Other Intangibles, Total	12.2M	1.06M	1.84M	238K	221K
Other Long-Term Assets, Total	2.18M	1.06M	766K	587K	740K
Total Assets	138M	96.23M	75.27M	53.67M	25.65M
Liabilities
Accounts Payable, Total	4.79M	3.29M	4.44M	2.72M	1.06M
Accrued Expenses, Total	3.99M	7.64M	7.63M	8.47M	13.9M
Short-term Borrowings	-	-	-	-	1M
Current Portion of Long-Term Debt	-	-	-	18.38M	23.43M
Current Portion of Leases	1.06M	868K	728K	1.22M	1.61M
Current Income Taxes Payable	-	1.9M	-	-	-
Unearned Revenue Current, Total	-	2.62M	2.54M	2.47M	2.58M
Other Current Liabilities	3.35M	692K	1.39M	3.18M	6.08M
Total Current Liabilities	13.19M	17M	16.73M	36.45M	49.67M
Long-Term Debt	-	-	18.9M	-	-
Long-Term Leases	1.1M	476K	1.62M	2.54M	1.44M
Unearned Revenue Non Current	2.83M	-	-	-	-
Other Non Current Liabilities	13.22M	11.82M	13.87M	12.84M	11.82M
Total Liabilities	30.34M	29.3M	51.1M	51.82M	62.93M
Common Stock, Total	1.4M	1K	1K	2K	2K
Additional Paid In Capital	695M	692M	696M	713M	722M
Retained Earnings	-606M	-637M	-661M	-700M	-748M
Treasury Stock	-8.03M	-9.33M	-9.6M	-9.6M	-9.6M
Comprehensive Income and Other	1.95M	-703K	-1.2M	-1.77M	-1.78M
Total Common Equity	84.5M	44.57M	24.16M	1.85M	-37.28M
Minority Interest	23.46M	22.36M	-	-	-
Total Equity	108M	66.93M	24.16M	1.85M	-37.28M
Total Liabilities And Equity	138M	96.23M	75.27M	53.67M	25.65M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.66M	13.32M	12.99M	15.49M	20.56M
ECS Total Common Shares Outstanding	13.98M	13.46M	13.38M	15.49M	20.56M
Book Value / Share	6.04	3.31	1.81	0.12	-1.81
Tangible Book Value	72.3M	43.51M	22.33M	1.61M	-37.5M
Tangible Book Value Per Share	5.17	3.23	1.67	0.1	-1.82
Total Debt	2.17M	1.34M	21.24M	22.14M	27.49M
Net Debt	-46.41M	-49.99M	-9.53M	6.05M	21.85M
Debt Equivalent Oper. Leases	11.62M	10.4M	8.8M	9.6M	9.6M
Minority Interest, Total (Incl. Fin. Div)	23.46M	22.36M	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	-	-	-	254K
Inventories - Work In Process, Total	-	-	-	-	504K
Inventories - Finished Goods, Total	1.91M	6.14M	15.88M	5.25M	840K
Machinery, Total	1.73M	1.24M	6.68M	6.58M	6.77M
Full Time Employees	176	224	176	233	214
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-36.65M	-41.01M	-26.94M	-39.26M	-48.06M
Depreciation & Amortization - CF	468K	1.21M	2.45M	1.27M	1.23M
Amortization of Goodwill and Intangible Assets - (CF)	1.35M	1.21M	1.29M	1.06M	28K
Depreciation & Amortization, Total	1.82M	2.42M	3.74M	2.33M	1.26M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	65K	2.06M	-	-479K	7K
(Gain) Loss on Sale of Investments - (CF)	-4.8M	3.57M	2.59M	-1.7M	179K
Asset Writedown & Restructuring Costs	6.56M	8.72M	-	696K	-
(Income) Loss On Equity Investments - (CF)	-	846K	48K	1.19M	2.19M
Stock-Based Compensation (CF)	7.77M	7.01M	7.22M	1.31M	2.99M
Other Operating Activities, Total	1.62M	1.95M	1.19M	5.92M	2.18M
Change In Accounts Receivable	-5.16M	-3.17M	3.42M	-5.79M	11.25M
Change In Inventories	-551K	-4.23M	-9.74M	5.83M	2.5M
Change In Accounts Payable	1.49M	1.07M	1.15M	-1.72M	-1.66M
Change in Unearned Revenues	-51K	-	-	-	-
Change In Income Taxes	-	1.98M	-1.89M	-	-
Change in Other Net Operating Assets	1.05M	-2.3M	-762K	2.45M	6.4M
Cash from Operations	-26.84M	-21.09M	-19.97M	-29.22M	-20.75M
Capital Expenditure	-8.94M	-5.61M	-204K	-223K	-16K
Sale of Property, Plant, and Equipment	10K	138K	-	-	-
Sale (Purchase) of Intangible assets	-6.56M	-	-2.04M	483K	-13K
Investment in Marketable and Equity Securities, Total	-	30.2M	-8.43M	10.98M	980K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-5.68M	-	1M	-	-
Other Investing Activities, Total	474K	6.44M	-	-	-
Cash from Investing	-20.69M	31.16M	-9.67M	11.24M	951K
Short Term Debt Issued, Total	709K	4M	-	-	6M
Total Debt Issued	709K	4M	-	-	6M
Short Term Debt Repaid, Total	-1.55M	-4M	-	-	-
Total Debt Repaid	-1.55M	-4M	-	-	-
Issuance of Common Stock	32.5M	-	109K	17.11M	5.93M
Repurchase of Common Stock	-	-3.27M	-278K	-	-
Common Dividends Paid	-	-	-738K	-718K	-
Common & Preferred Stock Dividends Paid	-	-	-738K	-718K	-
Other Financing Activities, Total	-2.02M	-	-	-960K	-681K
Cash from Financing	29.64M	-3.27M	-907K	15.43M	11.25M
Foreign Exchange Rate Adjustments	-469K	1.6M	518K	-1.07M	713K
Net Change in Cash	-18.36M	8.41M	-30.03M	-3.62M	-7.84M
Supplemental Items
Cash Interest Paid	42K	62K	-	-	4K
Cash Income Tax Paid (Refund)	-	-	1.81M	-	-
Levered Free Cash Flow	-27.36M	-17.41M	-13.71M	-15.22M	-651K
Unlevered Free Cash Flow	-27.33M	-17.41M	-13.71M	-14.67M	-126K
Change In Net Working Capital	-634K	4.68M	6.63M	-5.94M	-22.44M
Net Debt Issued / Repaid	-839K	0	-	-	6M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-16.58	-14.12	-18.43	-38.01	-67.52
Return on Total Capital	-20.33	-18.56	-27.8	-70.63	-377.27
Return On Equity %	-33.89	-46.04	-57.65	-301.8	271.28
Return on Common Equity	-44.15	-63.55	-78.44	-301.8	271.28
Margin Analysis
Gross Profit Margin %	58.38	63.28	59.19	39.06	48.65
SG&A Margin	127.52	87.63	123.49	145.23	225.06
EBITDA Margin %	-110.94	-55.84	-63.58	-129.24	-200.8
EBITA Margin %	-112.49	-58.65	-70.82	-133.69	-206.73
EBIT Margin %	-116.95	-61.45	-74.62	-137.41	-206.87
Income From Continuing Operations Margin %	-118.81	-93.39	-77.51	-137.57	-232.03
Net Income Margin %	-121.5	-95.14	-79.51	-137.57	-232.03
Net Avail. For Common Margin %	-121.5	-95.14	-79.58	-137.57	-232.03
Normalized Net Income Margin	-74.28	-36.44	-45.82	-89.22	-144.48
Levered Free Cash Flow Margin	-90.69	-40.39	-40.47	-53.32	-3.14
Unlevered Free Cash Flow Margin	-90.6	-40.39	-40.47	-51.42	-0.61
Asset Turnover
Asset Turnover	0.23	0.37	0.4	0.44	0.52
Fixed Assets Turnover	1.85	2.46	2.73	2.48	1.98
Receivables Turnover (Average Receivables)	4.18	3.79	3.01	2.29	2.13
Inventory Turnover (Average Inventory)	7.7	3.93	1.26	1.65	3.11
Short Term Liquidity
Current Ratio	4.7	4.32	3.55	1.09	0.27
Quick Ratio	4.43	3.78	2.45	0.86	0.2
Operating Cash Flow to Current Liabilities	-2.04	-1.24	-1.19	-0.8	-0.42
Days Sales Outstanding (Average Receivables)	87.4	96.43	121.33	159.65	171.27
Days Outstanding Inventory (Average Inventory)	47.42	92.77	290.57	222.33	117.54
Average Days Payable Outstanding	112.06	50.15	59.84	193.68	99.01
Cash Conversion Cycle (Average Days)	22.76	139.04	352.07	188.3	189.79
Long Term Solvency
Total Debt/Equity	2.01	2.01	87.89	1.2K	-73.72
Total Debt / Total Capital	1.97	1.97	46.78	92.28	-280.58
LT Debt/Equity	1.02	0.71	84.88	136.95	-3.87
Long-Term Debt / Total Capital	1	0.7	45.17	10.57	-14.71
Total Liabilities / Total Assets	21.94	30.45	67.89	96.55	245.35
EBIT / Interest Expense	-803.69	-	-	-45.02	-51.01
EBITDA / Interest Expense	-729.27	-	-	-40.97	-48.08
(EBITDA - Capex) / Interest Expense	-933.03	-	-	-41.22	-48.1
Total Debt / EBITDA	-0.07	-0.06	-1.04	-0.62	-0.68
Net Debt / EBITDA	1.45	2.2	0.47	-0.17	-0.54
Total Debt / (EBITDA - Capex)	-0.05	-0.05	-1.03	-0.62	-0.68
Net Debt / (EBITDA - Capex)	1.13	1.76	0.46	-0.17	-0.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	99.25	42.89	-21.41	-15.77	-27.42
Gross Profit, 1 Yr. Growth %	212.64	54.9	-26.5	-44.41	-9.6
EBITDA, 1 Yr. Growth %	6.74	-27.94	-10.51	71.23	12.77
EBITA, 1 Yr. Growth %	6.33	-25.36	-5.09	59.01	12.23
EBIT, 1 Yr. Growth %	5.91	-24.78	-4.57	55.11	9.27
Earnings From Cont. Operations, 1 Yr. Growth %	-24.56	12.32	-34.77	49.5	22.42
Net Income, 1 Yr. Growth %	-24.09	11.9	-34.32	45.73	22.42
Normalized Net Income, 1 Yr. Growth %	2.84	-29.76	-1.19	64.02	17.53
Diluted EPS Before Extra, 1 Yr. Growth %	-38.64	11.77	-32.85	26.73	1.27
Accounts Receivable, 1 Yr. Growth %	111.04	32.34	-26.38	60.66	-73.33
Inventory, 1 Yr. Growth %	40.63	221.87	158.67	-66.92	-69.57
Net Property, Plant and Equip., 1 Yr. Growth %	102.82	-39.37	-12.06	-2.35	-16.23
Total Assets, 1 Yr. Growth %	8.27	-30.42	-21.79	-28.69	-52.21
Tangible Book Value, 1 Yr. Growth %	5.81	-39.82	-48.69	-92.78	-2.43K
Common Equity, 1 Yr. Growth %	3.63	-47.25	-45.79	-92.34	-2.11K
Cash From Operations, 1 Yr. Growth %	3.69	-21.44	-5.32	46.36	-28.98
Capital Expenditures, 1 Yr. Growth %	496.73	-37.26	-96.36	9.31	-92.83
Levered Free Cash Flow, 1 Yr. Growth %	5.77	-36.2	-21.26	10.91	-95.72
Unlevered Free Cash Flow, 1 Yr. Growth %	5.68	-36.2	-21.26	7.01	-99.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	170.24	68.73	5.97	-18.64	-21.81
Gross Profit, 2 Yr. CAGR %	847.9	120.07	6.71	-36.08	-29.11
EBITDA, 2 Yr. CAGR %	-5.44	-12.38	-19.7	23.79	38.96
EBITA, 2 Yr. CAGR %	-5.54	-11	-15.83	22.84	33.59
EBIT, 2 Yr. CAGR %	-5.59	-10.83	-15.27	21.66	30.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-11.11	-7.95	-14.41	-1.25	35.28
Net Income, 2 Yr. CAGR %	-10.77	-7.84	-14.27	-2.16	33.57
Normalized Net Income, 2 Yr. CAGR %	-3.84	-15.09	-16.69	27.3	38.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-24.98	-17.02	-13.44	-7.78	13.29
Accounts Receivable, 2 Yr. CAGR %	175.35	67.12	-1.29	8.76	-34.54
Inventory, 2 Yr. CAGR %	-35.2	112.76	188.54	-7.5	-68.27
Net Property, Plant and Equip., 2 Yr. CAGR %	50.03	10.89	-26.98	-7.33	-9.56
Total Assets, 2 Yr. CAGR %	16.08	-13.2	-26.23	-25.32	-41.62
Tangible Book Value, 2 Yr. CAGR %	10.4	-20.2	-44.43	-80.75	29.61
Common Equity, 2 Yr. CAGR %	7.59	-26.06	-46.52	-79.62	24.21
Cash From Operations, 2 Yr. CAGR %	7.46	-9.74	-13.75	17.72	1.95
Capital Expenditures, 2 Yr. CAGR %	357.7	93.49	-84.9	-80.07	-71.99
Levered Free Cash Flow, 2 Yr. CAGR %	-1.03	-17.95	-29.12	-6.62	-78.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	-1.08	-17.95	-29.12	-8.21	-90.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	118.52	30.8	-1.84	-21.68
Gross Profit, 3 Yr. CAGR %	-	418.24	52.69	-14.14	-28.25
EBITDA, 3 Yr. CAGR %	10.46	-13.69	-11.76	3.36	20
EBITA, 3 Yr. CAGR %	10.43	-12.73	-9.07	4.05	19.2
EBIT, 3 Yr. CAGR %	10.01	-12.53	-8.79	3.65	17.38
Earnings From Cont. Operations, 3 Yr. CAGR %	9.27	-3.9	-17.93	3.08	6.08
Net Income, 3 Yr. CAGR %	10.09	-3.77	-17.68	2.31	5.43
Normalized Net Income, 3 Yr. CAGR %	10.65	-13.45	-10.69	4.41	23.96
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.91	-14.39	-22.72	-1.68	-4.86
Accounts Receivable, 3 Yr. CAGR %	-	115.68	27.16	16.11	-31.93
Inventory, 3 Yr. CAGR %	88.88	10.56	127.08	40.17	-36.15
Net Property, Plant and Equip., 3 Yr. CAGR %	131.84	10.92	2.64	-19.55	-10.4
Total Assets, 3 Yr. CAGR %	6.84	-2.12	-16.16	-27.06	-35.64
Tangible Book Value, 3 Yr. CAGR %	-7.27	-9.82	-31.12	-71.85	-4.83
Common Equity, 3 Yr. CAGR %	-8.27	-15.16	-33.33	-72.02	-5.78
Cash From Operations, 3 Yr. CAGR %	-2.07	-3.19	-8.29	2.87	-0.53
Capital Expenditures, 3 Yr. CAGR %	99.24	135.99	-48.56	-70.79	-85.82
Levered Free Cash Flow, 3 Yr. CAGR %	-12.16	-14.58	-19.07	-17.69	-66.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.19	-14.58	-19.07	-18.69	-80.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	47.19	6.47
Gross Profit, 5 Yr. CAGR %	-	-	-	124.37	12.33
EBITDA, 5 Yr. CAGR %	29.04	17.75	-2.81	-0.3	5.81
EBITA, 5 Yr. CAGR %	29.22	18.65	-0.98	0.06	6.05
EBIT, 5 Yr. CAGR %	30.23	19.76	-0.94	-0.19	5.16
Earnings From Cont. Operations, 5 Yr. CAGR %	30.54	30.17	-0.9	-2.85	0.23
Net Income, 5 Yr. CAGR %	31.13	30.66	-0.39	-3.13	-0.1
Normalized Net Income, 5 Yr. CAGR %	30.55	18.47	-1.26	0.99	6.55
Diluted EPS Before Extra, 5 Yr. CAGR %	9.8	11.45	-9.04	-11.81	-9.92
Accounts Receivable, 5 Yr. CAGR %	-	-	-	64.01	-2.5
Inventory, 5 Yr. CAGR %	-	-	123.77	2.95	3.34
Net Property, Plant and Equip., 5 Yr. CAGR %	148.64	66.09	46.04	3.22	-2.42
Total Assets, 5 Yr. CAGR %	37.92	16.37	-7.87	-12.16	-27.46
Tangible Book Value, 5 Yr. CAGR %	28.32	2.46	-24.45	-51.37	-11.31
Common Equity, 5 Yr. CAGR %	32.38	2.95	-26.08	-52.05	-14.49
Cash From Operations, 5 Yr. CAGR %	34.83	26.92	-6.92	4.69	-4.32
Capital Expenditures, 5 Yr. CAGR %	109.2	43.12	-29	-12.18	-59.67
Levered Free Cash Flow, 5 Yr. CAGR %	58.91	41.15	-19.42	-11.44	-52.12
Unlevered Free Cash Flow, 5 Yr. CAGR %	58.82	41.17	-19.42	-12.08	-65.54